| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB1266-SP | |||
| Carrier Free | IC1266V-100UG | |||
| Carrier Free | IC1266U-100UG | |||
| Carrier Free | IC1266T-100UG | |||
| Carrier Free | IC1266S-100UG | |||
| Carrier Free | IC1266R-100UG | |||
| Carrier Free | IC1266N-100UG | |||
| Carrier Free | IC1266G-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74101 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF1266-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB2234-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74100 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74101 | |||
![Western Blot: Serpin A5/Protein C Inhibitor Antibody (2D10) [NBP2-01833] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Protein C inhibitor (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Protein C inhibitor.](http://images.novusbio.com/fullsize/Serpin-A5-Protein-C-Inhibitor-Antibody-2D10-Western-Blot-NBP2-01833-img0008.jpg "Western Blot: Serpin A5/Protein C Inhibitor Antibody (2D10) [NBP2-01833] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Protein C inhibitor (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Protein C inhibitor.")
![Immunocytochemistry/Immunofluorescence: Serpin A5/Protein C Inhibitor Antibody (OTI2D10) [NBP2-01833] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY Protein C inhibitor.](http://images.novusbio.com/fullsize/Serpin-A5-Protein-C-Inhibitor-Antibody-2D10-Immunocytochemistry-Immunofluorescence-NBP2-01833-img0006.jpg)
![Immunohistochemistry-Paraffin: Serpin A5/Protein C Inhibitor Antibody (2D10) [NBP2-01833] - Staining of paraffin-embedded Human tonsil using anti-Protein C inhibitor mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Serpin-A5-Protein-C-Inhibitor-Antibody-2D10-Immunohistochemistry-Paraffin-NBP2-01833-img0007.jpg)
![Flow Cytometry: Serpin A5/Protein C Inhibitor Antibody (2D10) [NBP2-01833] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-Protein C inhibitor antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/Serpin-A5-Protein-C-Inhibitor-Antibody-2D10-Flow-Cytometry-NBP2-01833-img0005.jpg)
![Immunocytochemistry/Immunofluorescence: Serpin A5/Protein C Inhibitor Antibody [NBP3-17021] - Analysis in human testis and cerebral cortex tissues using Anti-SERPINA5 antibody. Corresponding SERPINA5 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/Serpin-A5-Protein-C-Inhibitor-Antibody-Immunocytochemistry-Immunofluorescence-NBP3-17021-img0001.jpg "Immunocytochemistry/Immunofluorescence: Serpin A5/Protein C Inhibitor Antibody [NBP3-17021] - Analysis in human testis and cerebral cortex tissues using Anti-SERPINA5 antibody. Corresponding SERPINA5 RNA-seq data are presented for the same tissues.")
![Immunohistochemistry-Paraffin: Serpin A5/Protein C Inhibitor Antibody [NBP3-17021] - Staining of human cerebral cortex shows low expression as expected.](http://images.novusbio.com/fullsize/Serpin-A5-Protein-C-Inhibitor-Antibody-Immunohistochemistry-Paraffin-NBP3-17021-img0002.jpg)
![Immunohistochemistry-Paraffin: Serpin A5/Protein C Inhibitor Antibody [NBP3-17021] - Staining of human testis shows high expression.](http://images.novusbio.com/fullsize/Serpin-A5-Protein-C-Inhibitor-Antibody-Immunohistochemistry-Paraffin-NBP3-17021-img0003.jpg)
![Western Blot: Serpin A5/Protein C Inhibitor Antibody (1C4) [NBP2-45764] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Serpin A5/Protein C Inhibitor.](http://images.novusbio.com/fullsize/Serpin-A5-Protein-C-Inhibitor-Antibody-1C4-Western-Blot-NBP2-45764-img0002.jpg "Western Blot: Serpin A5/Protein C Inhibitor Antibody (1C4) [NBP2-45764] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Serpin A5/Protein C Inhibitor.")
![Flow Cytometry: Serpin A5/Protein C Inhibitor Antibody (1C4) [NBP2-45764] - Analysis of HEK293T cells transfected with either overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by SERPINA5 antibody.](http://images.novusbio.com/fullsize/Serpin-A5-Protein-C-Inhibitor-Antibody-1C4-Flow-Cytometry-NBP2-45764-img0001.jpg)
![Western Blot: Protein C inhibitor Overexpression Lysate (Adult Normal) [NBL1-15839] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for Protein C inhibitor.](http://images.novusbio.com/fullsize/Protein-C-inhibitor-Overexpression-Lysate-Adult-Normal-Western-Blot-NBL1-15839-img0002.jpg "Western Blot: Protein C inhibitor Overexpression Lysate (Adult Normal) [NBL1-15839] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for Protein C inhibitor.")
![ELISA: Human Serpin A5/Protein C Inhibitor - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-39030] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp3-39030_human-serpin-a5-protein-c-inhibitor-r-t-u-elisa-kit-2110202415403160.png "ELISA: Human Serpin A5/Protein C Inhibitor - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-39030] - Standard Curve Reference")
![ELISA: Human Serpin A5/Protein C Inhibitor ELISA Kit (Colorimetric) [NBP3-39029] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp3-39029_human-serpin-a5-protein-c-inhibitor-elisa-kit-colorimetric-2110202415305255.png "ELISA: Human Serpin A5/Protein C Inhibitor ELISA Kit (Colorimetric) [NBP3-39029] - Standard Curve Reference")